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ABSTRACT
Objectives: To evaluate the influence of a single intraoperative injection of methylprednisolone on short-term haematological 
parameters following surgical removal of mandibular third molars.
Material and Methods: Fifty-two patients with indications for surgical removal of bilateral impacted mandibular third 
molars were included in a randomized, split-mouth and double-blinded study design. Each molar were randomly allocated 
into one of following four groups: 20 mg methylprednisolone, 30 mg methylprednisolone, 40 mg methylprednisolone and 
placebo. Peripheral blood samples were obtained before and three days after surgery. Haematological parameters involving 
haemoglobin, white blood cell count and C-reactive protein (CRP) were evaluated and expressed as mean changes. Level of 
significance was 0.05. Furthermore, outcomes were correlated for age, sex, smoking and time of surgery.
Results: There were no significant differences in postoperative haematological parameters with different doses of 
methylprednisolone compared with placebo. Peripheral blood samples revealed decreased level of haemoglobin and increased 
level of leucocytes and CRP in each group. Smokers displayed a significant lower level of haemoglobin and CRP compared 
with non-smokers (P < 0.05) and level of eosinophils decreased significantly with increasing age (P < 0.05).
Conclusions: This study indicates that a single intraoperative injection of methylprednisolone seems not to cause suppression 
of short-term haematological parameters compared with placebo following surgical removal of mandibular third molars.
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INTRODUCTION
Surgical removal of mandibular third molars (M3s) 
is a common surgical procedure in dentistry and 
oral and maxillofacial surgery. Facial swelling, pain 
and trismus are well-known sequelae caused by an 
inflammatory response to the surgical trauma [1,2]. 
Prophylactic measures including pharmacological 
therapies, cryotherapy, local compression and 
surgical drains are frequently used to diminish the 
inflammatory response following surgical removal 
of M3 [3-7]. Corticosteroids are synthetic analogues 
of natural steroid hormones produced by the adrenal 
cortex and have potent anti-inflammatory properties 
[8,9]. The clinical efficacy of synthetic corticosteroids 
to diminish postoperative sequelae following surgical 
removal of M3 have previously been assessed in 
systematic reviews and meta-analyses [10-13].
Systemic or local administration of corticosteroids 
interact with biochemical and haematological 
parameters including haemoglobin, white blood cell 
counts and C-reactive protein (CRP) [14-17]. Level 
of haemoglobin in peripheral blood is increased 
after administration of corticosteroid, possibly 
by retarding erythrophagocytosis [16]. Level of 
leucocytes is also increased after administration of 
corticosteroids due to increase rate of entrance from 
bone marrow and decrease rate of removal from the 
vascular compartment [18], whereas diminished 
level of lymphocytes, eosinophils, monocytes and 
basophils have been reported after administration 
of corticosteroids [18,19]. Level of CRP after 
tissue injury or inflammation is decreased after 
corticosteroid therapy due to diminish formation 
of cytokines [17,20]. It has been reported that the 
influence of corticosteroids on biochemical and 
haematological parameters depends on administration 
route, dosages and therapy duration [19]. A previous 
study estimated number of peripheral eosinophils after 
perioral administration of preoperative corticosteroids 
following surgical removal of M3 [21]. Facial 
swelling was statistically significant diminished 
after administration of hydrocortisone and a 50% 
reduction in the level of eosinophils compared with 
placebo. However, assessment of haematological 
parameters after systemic or local administration 
of corticosteroids following surgical removal of 
M3 has never previously been assessed. Therefore, 
the purpose of this double-blinded randomized 
controlled trial was to assess the influence of a single 
intramuscular injection of methylprednisolone on 
short-term haematological parameters, changes in 
inflammatory response and possible side effects 
compared with placebo following surgical removal of 
mandibular third molars.
MATERIAL AND METHODS
Study design and sample
The study was conducted at the Department of 
Oral and Maxillofacial Surgery, Aalborg University 
Hospital, Denmark between March 2018 and January 
2019. The study protocol was approved by the Danish 
Health and Medicines Authority, Research Ethics 
Committee and Danish Data Protection Agency 
(approval no. N-20170016). The study was performed 
in accordance with Good Clinical Practice (GCP), 
Declaration of Helsinki II and Consolidated Standards 
of Reporting Trials (CONSORT) statement [22]. 
Patients were recruited by public invitation through 
Facebook, personal contacts or scheduled for surgical 
removal of M3 due orthognathic treatment of a facial 
deformity. Oral and written information regarding the 
study was provided prior to enrolment, and written 
informed consent was obtained from all included 
patients. Participation was voluntary, and patients 
could at any given time withdraw from the study. 
Sample size calculation
Sample size was calculated using Clincalc.com 
(http://clincalc.com/stats/samplesize.aspx) to ensure 
adequate power for the study including a difference 
of 20 mm in VAS score on the first postoperative day. 
Analysis revealed that 16 patients per group would be 
necessary to provide 80% power with an alpha value 
of 0.05. Sample size was increased to 26 M3 in each 
group to compensate for possible dropouts.
Study population
Patients scheduled for surgical removal of bilateral 
impacted M3 were included. Position of M3 was 
assessed on panoramic radiograph and classified using 
Pell and Gregory system and Winters classification 
[23]. Inclusion and exclusion criteria are outlined in 
Table 1.
Randomization and blinding
A computer-aided randomization was used to allocate 
each M3 cases into four groups. A randomization 
scheme was fabricated including an allocation 
number for each M3. The pharmacy at Aalborg 
University Hospital, Aalborg, Denmark, preserved 
the randomization scheme until the study was 
unblinded. An assistant nurse received an e-mail with 
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the randomization numbers and allocated each M3 
case into one of the following four groups:
• Group I: placebo (isotonic saline solution);
• Group II: 20 mg methylprednisolone;
• Group III: 30 mg methylprednisolone;
• Group IV: 40 mg methylprednisolone.
Patients, surgeon, dental assistant as well as assessor 
were not informed about the allocation group. A 
trained assistant nurse fabricated syringes containing 
either placebo or methylprednisolone. All syringes 
contained 1.05 mL of mixtures. Syringes containing 
methylprednisolone were mixed with isotonic saline 
solution. The colour of the mixtures was identical. 
Thus, each syringe from the four groups had similar 
appearance and quantity.
Haematological parameters
Blood samples were obtained by a medical laboratory 
technologist at Aalborg University Hospital, 
Denmark. Blood samples were collected from each 
patient before (T0) and three days (T1) after surgical 
removal of M3 with no regard to time of the day, 
physical activity or fasting. Data were registered 
and stored in the patients’ case report file. A total of 
8 mL of whole blood was collected from the cubital 
vein. Complete haemogram test of the blood samples 
was conducted within two hours by Sysmex XN-
9000 haematology analyzer (Sysmex Europe GmbH; 
Norderstedt, Germany) and Cobas 8000 (Roche 
Diagnostics International Ltd; Rotkreuz, Switzerland). 
Level of haemoglobin (mmol/L), leucocytes (counts 
x 109/L), neutrophils (counts x 109/L), eosinophils 
(counts x 109/L) and CRP (counts/L) were analysed.
Surgical procedure
A standardized surgical procedure was performed 
in all patients by the same trained surgeon (MKL). 
Patients had one M3 removed at each time. 
Removal of the contralateral M3 was scheduled, four 
to six weeks later. All patients received prophylactic 
analgesic including 400 mg ibuprofen (Ipren® - 
Takeda Pharma A/S; Hobro, Denmark) and 1,000 mg 
paracetamol (Pinex®, Actavis Nordic A/S; Søborg, 
Denmark), one hour prior to surgery.
Surgical removal of M3 was performed under 
local anaesthesia with 20 mg/mL mepivacaine 
hydrochloride and 5 µg/mL adrenaline (Carbocain-
Adrenalin® - AstraZeneca; Copenhagen, Denmark). 
Immediately after application of local anaesthesia, 
an injection of methylprednisolone or placebo was 
given in the masseter muscle at the ipsilateral site. A 
mucosal incision was made from the anterior border 
of the ascending mandibular ramus to the distal part 
of the second molar continuing marginal to the lower 
first molar. The mucosal flap was elevated. Facial and 
distal bone removal around the M3 was performed 
with a round burr on a straight hand-piece under 
continuous irrigation with saline. Sectioning of the 
crown  or roots was performed as necessary with a 
fissure bur and the same hand-piece. Extraction socket 
and surrounding bone was copiously irrigated with 
a saline solution, and the mucosal flap was sutured 
with a resorbable suture (Ethicon Vicryl Rapide™ 
suture 4-0 - Johnson and Johnson  Medical Gmbh; 
Norderstedt, Germany). A small gauze pack was 
applied to the surgical site and usual postoperative 
instructions were given to the patients.
Postoperative medications included 400 mg of 
ibuprofen three times a day (Ipren®) and 1.000 mg 
paracetamol (Pinex®) four times a day. Patients were 
also instructed to mouth rinse three times a day with 
0.12% chlorhexidine (Klorhexidin Mundskyl 0.12% - 
Faaborg Pharma; Faaborg, Denmark).
Statistical analysis
Data management and statistical analysis was 
performed with Excel, version 2013 (Microsoft; 
Redmond, Washington, USA) and R, version 3.6.1 
(Missouri, USA). Difference in level of haemoglobin, 
Table 1. Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
- Bilateral symmetrical impacted mandibular third molars.
- Indication for removal of mandibular third molars.
- Age between 18 and 40 years.
- Acute infection in the oral cavity at the time of surgery.
- Previous maxillofacial trauma.
- Craniofacial clefts or syndromes.
- Systemic bone disease (i.e. arthritis) or diabetes mellitus.
- Active acne vulgaris, viral and fungal infections.
- Psychological disease.
- Medication as bisphosphonate, anticoagulants and other drugs that have 
an influence on corticosteroids.
- Pregnancy and breastfeeding.
- Failure to attend follow-up.
- Known allergy to methylprednisolone and other inactive ingredients.
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leucocytes, neutrophils, eosinophils and CRP were 
analysed with a generalized estimating equation 
analysis, Generalized Estimating Equation analysis 
to compensate for the fact that some data were not 
normal distributed. The results were expressed as mean 
with a 95% confidence interval (CI). P value less than 
0.05 was considered as statistically significant. The 
analysis was descriptive and adjusted for age, sex, 
smoking and time of surgery. Parametric data were 
expressed as mean and standard deviation (M [SD]).
Descriptive analysis of secondary categorical 
variables including smoking habits, anatomical 
position of M3 and infection rate was analysed using 
Fishers exact test, when the number of observations in 
each category was not unreasonably small.
RESULTS
Study population
The present study included 52 patients (16 men and 
36 female) with a mean age of 25.9 (6) years (range 
from 18 to 39) and surgical removal of 104 M3 
(Table 2 and Figure 1). One patient dropped out 
Figure 1. Consort flow diagram.
Table 2. Baseline characteristics
Variable Level Placebo(n = 26)
20 mg
(n = 26)
30 mg
(n = 26)
40 mg
(n = 26)
Total
(n = 104)
Sex, N (%)
Male 8 (30.8) 8 (30.8) 8 (30.8) 8 (30.8) 32 (30.8)
Female 18 (69.2) 18 (69.2) 18 (69.2) 18 (69.2) 72 (69.2)
Age, years
Mean (SD) 24.62 (4.97) 26.81 (6.52) 25.62 (6.17) 26.65 (6.28) 25.92 (5.99)
Median 24 25.5 23 24 24
Q1; Q3 21; 26.75 22; 30 21; 29 22.25; 30 21; 29
Min 18 18 18 18 18
Max 38 39 39 39 39
Smoking, N (%)
No 24 (92.3) 24 (92.3) 22 (84.6) 24 (92.3) 94 (90.4)
Yes 2 (7.7) 2 (7.7) 4 (15.4) 2 (7.7) 10 (9.6)
N = number; Q1 = first quartile; Q3 = third quartile; SD = standard deviation. 
Assessed for eligibility 
(n = 106) 
Randomised 
(n = 106) 
Enrolment 
Allocation 
Follow-up 
Analysis 
Analysed 
(n = 26) 
Analysed 
(n = 26) 
Analysed 
(n = 26) 
Analysed 
(n = 26) 
Dropped-out 
(n = 2) 
Allocated to 40 mg 
methylprednisolone 
(n = 26) 
Allocated to 30 mg 
methylprednisolone 
(n = 26) 
Allocated to 20 mg 
methylprednisolone 
(n = 26) 
Allocated to 
placebo 
(n = 26) 
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during the inclusion period and was replaced by 
another patient. No statistically significant differences 
were found in the demographic as well as clinical and 
radiographic characteristics among the study groups 
including gender, age, anatomical classification of 
the M3 (P = 0.66), smoking (P = 0.836) and time of 
surgery (P = 0.33) (Table 2 and 3). Mean surgical time 
was 9.42 (5.18) minutes. Patients underwent surgical 
removal of one M3, while the other M3 was removed 
after 58.8 days (range from 8 to 157). The study was 
unblinded 13th of May 2019.
Postoperative antibiotics involving 
phenoxymethylpenicillin 800 mg (Primcillin® - 
Meda A/S; Ballerup, Denmark) four times a day 
and metronidazole 500 mg (Metronidazol “DAK” 
- Takeda Pharma A/S; Hobro, Denmark) two times a 
day for seven days) were prescribed in 22 cases out of 
104 (21.1%) due to major swelling, pus or increased 
body temperature. Distribution of infection among the 
four groups was equal with no significant difference 
(P = 0.676). Postoperative bleeding occurred in two 
cases out of 104 (1.9%). The bleeding was sufficient 
treated with additional sutures and compression. 
None of the patients complained of discomfort or 
complications related to blood samples. No further 
complications were observed. 
Haemoglobin
Mean level of haemoglobin decreased in all 
groups from 8.79 (0.79) mmol/L (T0) to 8.51 
(0.74) mmol/L (T1). There were no significant 
differences in the level of haemoglobin from T0 to 
T1 between 20 mg methylprednisolone (P = 0.606), 
30 mg methylprednisolone (P = 0.404) or 40 mg 
methylprednisolone (P = 0.828) compared with 
placebo (Table 4A and Figure 2). No significant 
differences in the level of haemoglobin were observed 
from T0 to T1, when results were adjusted for age 
(P = 0.573), sex (P = 0.212) and time of surgery (P 
= 0.616). However, a significant difference in the 
level of haemoglobin was observed, when the results 
were adjusted for smoking (P < 0.05) indicating 
that smokers display a lower level of haemoglobin 
compared with non-smokers at T0 and T1, respectively.
White blood cell count
Mean level of leucocytes increased in all groups 
from 6.33 (1.36) 109/L (T0) to 7.85 (2.18) 109/L (T1). 
There were no significant differences in the level 
of leucocytes between 20 mg methylprednisolone 
(P = 0.449), 30 mg methylprednisolone (P = 0.761) 
and 40 mg methylprednisolone compared with 
placebo (P = 0.872) from T0 to T1 (Table 4A and 
Figure 3). No significant differences in the level of 
leucocytes were observed from T0 to T1, when results 
were adjusted for age (P = 0.805), sex (P = 0.814), 
smoking (P = 0.674) and time of surgery (P = 0.139).
Mean level of neutrophils increased in all groups 
from 3.44 (1.12) 109/L (T0) to 4.88 (1.96) 109/L (T1). 
There were no significant differences in the level of 
neutrophils between 20 mg methylprednisolone (P = 
0.562), 30 mg methylprednisolone (P = 0.454) and 
40 mg methylprednisolone compared with placebo 
(P = 0.555) from T0 to T1 (Table 4B and Figure 4). 
Table 3. Anatomical position of mandibular third molars and time of surgery
Variable Level Placebo(n = 26)
20 mg
(n = 26)
30 mg
(n = 26)
40 mg
(n = 26)
Total
(n = 104)
Anatomical position (Winter), N (%)
1 10 (38.5) 8 (30.8) 10 (38.5) 5 (19.2) 33 (31.7)
2 6 (23.1) 8 (30.8) 4 (15.4) 10 (38.5) 28 (26.9)
3 5 (19.2) 4 (15.4) 8 (30.8) 6 (23.1) 23 (22.1)
4 5 (19.2) 6 (23.1) 4 (15.4) 5 (19.2) 20 (19.2)
Anatomical position (Pell and Gregory 
transversal), N (%)
1 0 (0) 1 (3.8) 0 (0) 0 (0) 1 (1)
2 26 (100) 24 (92.3) 26 (100) 26 (100) 102 (98.1)
3 0 (0) 1 (3.8) 0 (0) 0 (0) 1 (1)
Anatomical position (Pell and Gregory vertical), 
N (%)
1 7 (26.9) 5 (19.2) 9 (34.6) 8 (30.8) 29 (27.9)
2 18 (69.2) 18 (69.2) 16 (61.5) 16 (61.5) 68 (65.4)
3 1 (3.8) 3 (11.5) 1 (3.8) 2 (7.7) 7 (6.7)
Time of surgery (minutes)
Mean (SD) 9.27 (3.79) 8.77 (3.9) 9.04 (5.87) 11.73 (6.77) 9.7 (5.3)
Median 9.5 7 6 9.5 8
Q1; Q3 6; 10 6; 10.75 5.25; 10 8; 15.75 6; 11.25
Min; max 5; 18 5; 20 4; 30 4; 31 4; 31
N = number; Q1 = first quartile; Q3 = third quartile; SD = standard deviation.
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No significant differences in the level of neutrophils 
were observed from T0 to T1, when results were 
adjusted for age (P = 0.531), sex (P = 0.563), 
smoking (P = 0.671) and time of surgery (P = 
0.055).
Mean level of eosinophils decreased in all groups 
from 0.17 (0.11) 109/L (T0) to 0.14 (0.08) 109/L (T1). 
There were no significant differences in the level 
of eosinophils between 20 mg methylprednisolone 
(P = 0.612), 30 mg methylprednisolone (P = 0.956) 
and 40 mg methylprednisolone compared with 
placebo (P = 0.775) from T0 to T1 (Table 4B and 
Figure 5). No significant differences in level of 
eosinophils were observed from T0 to T1, when 
results were adjusted for sex (P = 0.411), smoking 
(P = 0.061) and time of surgery (P = 0.385). However, 
a significant difference in the level of eosinophils was 
seen from T0 to T1, when the results were adjusted for 
age (P = 0.05) revealing a larger reduction in level of 
eosinophils at T1 with increasing age. 
Figure 2. Boxplot of the level of haemoglobin (mmol/L) before and three days after intramuscular 
administration of methylprednisolone and surgical removal of mandibular third molar (M3).
Figure 3. Boxplot of the level of leucocytes (/L) before and three days after intramuscular administration 
of methylprednisolone and surgical removal of mandibular third molar (M3).
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Table 4A. Results of blood sampling. The difference between before surgery and three days after surgery
Group
Haemoglobin Leucocytes
Estimate 95% CI SD P Estimate 95% CI SD P
0 mg Reference - - - - - - -
20 mg -0.05 -0.22; 0.13 0.088 0.606 0.39 -0.62; 1.4 0.517 0.449
30 mg 0.08 -0.11; 0.28 0.101 0.404 -0.19 -1.42; 1.04 0.629 0.761
40 mg 0.02 -0.15; 0.19 0.087 0.828 0.09 -0.98; 1.16 0.546 0.872
CI = confidence interval; SD = standard deviation.
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Table 4B. Results of blood sampling. The difference between before surgery and three days after surgery
Group
Neutrophils Eosinophils C-reactive protein
Estimate 95% CI SD P Estimate 95% CI SD P Estimate 95% CI SD P
0 mg - - - - - - - - - - - -
20 mg 0.27 -0.64; 1.19 0.467 0.562 0.009 -0.03; 0.05 0.019 0.612 -4.78 -17.65; 8.08 6.565 0.466
30 mg -0.45 -1.61; 0.72 0.594 0.454 -0.001 -0.04; 0.04 0.019 0.956 -10.26 -20.31; -0.2 5.131 < 0.05
40 mg -0.3 -1.28; 0.68 0.5 0.555 -0.005 -0.04; 0.03 0.019 0.775 -9.92 -22.17; 2.32 6.249 0.112
CI = confidence interval; SD = standard deviation.
Figure 4. Boxplot of the level of neutrophils (x109/L) before and three days after intramuscular 
administration of methylprednisolone and surgical removal of mandibular third molar (M3).
Figure 5. Boxplot of the level of eosinophils (x109/L) before and three days after intramuscular 
administration of methylprednisolone and surgical removal of mandibular third molar (M3).
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C-reactive protein
Mean level of CRP increased in all groups from 
2.36 (2.63)/L (T0) to 14.92 (22.03)/L (T1). There 
were no significant differences in the level of CRP 
between 20 mg methylprednisolone (P = 0.466) and 
40 mg methylprednisolone (P = 0.112) compared 
with placebo from T0 to T1. However, mean 
level of CRP was significantly decreased with 30 
mg methylprednisolone compared with placebo 
(P < 0.05) from T0 and T1 (Table 4B and Figure 
6). No significant differences in the level of CRP 
were observed from T0 to T1, when the results 
were adjusted for age (P = 0.748), sex (P = 0.83) 
and time of surgery (P = 0.104). However, a 
statistically significant difference in the level of 
CRP was seen between smokers and non-smokers 
(P < 0.05) at T1 indicating that smokers have a lower 
increase in the level of CRP compared with non- 
smokers. 
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DISCUSSION
Indication for the use of corticosteroids or other 
medications to diminish postoperative sequelae 
following surgical removal of M3 is an important 
consideration for healthcare professionals. Advantages 
and disadvantages should always be considered, 
especially if the drugs interfere or suppress normal 
body functions. However, haematological parameters, 
adrenal insufficiency or increased risk of infections 
following surgical removal of M3 with administration 
of different doses of corticosteroids have never 
previously been investigated. The present double-
blinded randomized controlled trial demonstrated no 
significant differences in short-term haematological 
parameters following surgical removal of M3 with a 
single intramuscular injection of methylprednisolone 
compared with placebo. Postoperative peripheral 
blood samples revealed generally decrease in level of 
haemoglobin and an increase in level of leucocytes 
and CRP compared with preoperative blood levels. 
Subgroup analyses indicated that increased age 
and smoking influence haematological parameters 
following surgical removal of M3.
Synthetic corticosteroids display dissimilar 
pharmacokinetic properties and duration of action 
[10]. Methylprednisolone was used in the present 
study since other synthetic corticosteroids are not 
available in Denmark for intramuscular injection 
following surgical removal of M3. Methylprednisolone 
is classified as intermediate duration of action with 
plasma half-life time of 3 to 4 hours and duration of 
action of 12 to 36 hours [24]. Consequently, peripheral 
blood samples were obtained before surgery and after 
three days, when methylprednisolone’s duration of 
action of was ended and haematological parameters 
were anticipated to be normalized.
Synthetic corticosteroids are widely used for 
management of inflammatory and immunologic 
conditions, such as allergies, rashes, asthma 
or arthritis [17,25,26]. Adrenal suppression, 
cardiovascular disease, Cushing’s syndrome, 
dyslipidaemia, hyperglycaemia, immunosuppression 
and osteoporosis are well-known side effects 
associated with long-term corticosteroid therapy 
[27]. Local or systemic administration of a single 
dosage of corticosteroid is often used to diminish the 
inflammatory response following surgical removal 
of M3 [10]. However, adrenal suppression or severe 
side effects related to a single dosage of corticosteroid 
have never previously been described following 
surgical removal of M3 [10,11,28].
Systemic or local administration of synthetic 
corticosteroid interacts with haematological and 
biochemical parameters. Levels of haemoglobin and 
leucocytes in peripheral blood are usually increased 
following corticosteroid therapy [16,18]. In the 
present study, no statistical significant difference was 
observed in the level of haematological parameters 
between different dosages of methylprednisolone 
compared with placebo. However, the mean level 
of CRP was significantly decreased with 30 mg 
methylprednisolone compared with placebo indication 
a lower inflammatory reaction. Levels of CRP are 
influenced by various confounding factors including 
postoperative infection, time of surgery, body mass 
index, lack of exercise and medical conditions 
[29,30]. Moreover, anti-inflammatory drugs may 
cause a decrease in CRP levels. In the present study, 
subgroup analyses revealed equal distribution of 
postoperative infections and time of surgery among 
the four groups. Association between body mass index 
and daily physical functioning were not correlated to 
Figure 6. Boxplot of the level of C-reactive protein (mg/L) before and three days after intramuscular 
administration of methylprednisolone and surgical removal of mandibular third molar (M3).
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levels of CRP and registration of quantity as well as 
time period of need for painkillers was not performed. 
The reported significant difference in CRP after 
administration of 30 mg methylprednisolone may 
therefore be related to another cause. Consequently, 
a single dosage of methylprednisolone seems not to 
significantly influence haematological parameters 
following surgical removal of M3. 
Haematological parameters are influenced by various 
factors, including age, gender, ethnicity, diet, life-
style, medication, anaemia, pregnancy, smoking and 
bleeding [25,26]. Therefore, patients with medical 
conditions, pregnancy or medical prescription 
influencing haematological parameters were excluded 
from the present study. Furthermore, results of 
peripheral blood samples were adjusted for age, 
gender, smoking and time of surgery.
Elderly patients are characterized by decreased 
level of haemoglobin and leucocytes in peripheral 
blood [24,26,31]. In the present study, there were no 
significant differences in the level of haemoglobin 
and leucocytes, when the results were correlated 
for age. However, patients’ age ranged between 18 
and 39 years, which might explain the reason for no 
statistical difference in the haematological parameters. 
However, pre- and postoperative peripheral blood 
samples revealed a significantly larger decreased in the 
level of eosinophils with increasing age. This result is 
in accordance with the literature demonstrating that 
levels of eosinophils decrease with advancing age [32].
Normal range of haemoglobin differs between 
genders and males generally have higher haemoglobin 
values than females [24,33]. In the present study, 
no statistically significant difference in the level of 
haemoglobin was observed between genders after 
administration of methylprednisolone compared 
with placebo. Thus, gender seems not to influence 
haematological parameters following surgical removal 
of M3 with a single intramuscular injection of 
methylprednisolone compared with placebo.
Smoking increases the level of haemoglobin, 
leucocytes and CRP in peripheral blood compared 
with non-smoking [34,35]. In the present study, there 
was no significant difference in level of leucocytes 
between smokers and non-smokers. However, a 
significant lower level of haemoglobin and CRP was 
observed in smokers compared with non-smokers. 
These results seems not to be in accordance with 
previous studies [34,35]. But only, five low smokers 
were included in the present study. Thus, the influence 
of smoking on haematological parameters within this 
study may not be representative. 
Prolonged time of surgery may cause a decrease in the 
level of haemoglobin due to increased blood loss [36]. 
Surgical removal of M3 is usually associated 
with minor blood loss, though life-threatening 
haemorrhage has been reported [37]. Decreased level 
of haemoglobin following surgical removal of M3 is 
therefore not anticipated due to the insignificant blood 
loss. However, mean level of haemoglobin decreased 
in all groups, although blood loss were diminutive in 
all patients and no statistically significant difference in 
the level of haemoglobin was observed when the time 
of surgery was increased. Postoperative bleeding was 
observed in two patients, which did not affect the level 
of haemoglobin. Furthermore, level of leucocytes or 
CRP was not influenced by the time of surgery. 
The present study is characterized by following 
limitations including small sample size, inclusion 
of smokers and non-smokers, dissimilar gender 
distribution and blood samples at different times 
with no regard to fast, sleep and physiological 
activities. Moreover, the life span of erythrocytes is 
approximately 90 days. Bone marrow suppression 
or disturbed erythropoiesis caused by a single dose 
of corticosteroids would therefore not be detectable 
in blood samples after solely three days. Assessment 
of long-term haematological parameters is therefore 
needed in further studies. Consequently, conclusions 
drawn from the present study should be interpreted 
with caution.
CONCLUSIONS
In conclusion, a single, intramuscular injection of 
methylprednisolone seems not to influence the short-
term haematological parameters compared with 
placebo following surgical removal of mandibular 
third molars. However, further randomized controlled 
trials including larger patient samples, homogenous 
study groups and comparison of different synthetic 
corticosteroids are needed before definite conclusions 
can be provided about the influence of synthetic 
corticosteroids on haematological parameters 
following surgical removal of mandibular third molars.
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